BioMarin Pharmaceuticals (BMRN) Misses Q4 EPS by 12c; Guides FY12 Revs Below
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St subdued in choppy trade after big bank earnings, chips slide
- Oil prices ease as US-Russia diesel deal hopes offset Middle East attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 54.17 -1.22 (2.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.39 | 52 Week High | $108.96 | |||
| Open | $55.30 | 52 Week Low | $62.12 | |||
| Day High | $55.66 | P/E | N/A | |||
| Day Low | $54.03 | EPS | $-1.27 | |||
| Volume | 913,154 | |||||
